High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration

Figure 3

Correlation between PDLIM2 mRNA expression and mutation frequencies of prostate cancer-associated genes. (a) Gene mutation frequencies in TCGA-PRAD. (b) TMB scores of the high- and low-PDLIM2 groups using data from TCGA database. (c–e) Violin plots examining the effect of PTEN, FOXA1, and TTN gene mutations on PDLIM2 mRNA expression in prostate cancer.

(a)

(b)

(c)

(d)

(e)